A STEP TOWARDS PRECISION MEDICINE
New Cancer Drug Approved A new class of cancer drug that can treat a wide range of tumors has been approved for use in Europe. Researchers across the world consider it revolutionary. This approval is a first of its kind, and the doctors termed it as 'exciting'. According to the doctors, tumour- agnostic drug are specific in its mode of action as it targets the genetic abnormality in contrast to conventional chemotherapy. The new cancer drug has the potential to remove side effects. Charlotte Stevenson, a two year old from Belfast. was one of the first patients to benefit from the new cancer drug which was approved. She was diagnosed from infantile fibrosarcoma. It is a cancer of the body's connective tissue. She has been treated with larotrectinib as part of clinical trial. Infantile fibrosaecoma is caused due to genetic defect abnormality know as NTRK gene fusion. One part pf the DNA merge with another. This led to an alteration in the blueprint in h